151 related articles for article (PubMed ID: 10910834)
21. Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation.
Della Rocca G; Coccia C; Costa MG; Pompei L; Di Marco P; Vizza CD; Venuta F; Rendina EA; Pietropaoli P; Cortesini R
Transplant Proc; 2001; 33(1-2):1634-6. PubMed ID: 11267451
[No Abstract] [Full Text] [Related]
22. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
23. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of nebulised epoprostenol in pulmonary hypertension due to systemic sclerosis.
Parameswaran K; Purcell I; Farrer M; Holland C; Taylor IK; Keaney NP
Respir Med; 1999 Feb; 93(2):75-8. PubMed ID: 10464856
[TBL] [Abstract][Full Text] [Related]
25. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
26. Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room.
Bhatt AM; Stein EJ
Anesthesiology; 2017 Aug; 127(2):383. PubMed ID: 28323647
[No Abstract] [Full Text] [Related]
27. Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.
Saggar R; Khanna D; Vaidya A; Derhovanessian A; Maranian P; Duffy E; Belperio JA; Weigt SS; Dua S; Shapiro SS; Goldin JG; Abtin F; Lynch JP; Ross DJ; Forfia PR; Saggar R
Thorax; 2014 Feb; 69(2):123-9. PubMed ID: 24431095
[TBL] [Abstract][Full Text] [Related]
28. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide inhalation modulates endothelin-1 plasma concentration gradients following left ventricular assist device implantation.
Wagner F; Buz S; Neumeyer HH; Hetzer R; Hocher B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S89-91. PubMed ID: 15838368
[TBL] [Abstract][Full Text] [Related]
30. Inhaled therapy for the management of perioperative pulmonary hypertension.
Thunberg CA; Morozowich ST; Ramakrishna H
Ann Card Anaesth; 2015; 18(3):394-402. PubMed ID: 26139748
[TBL] [Abstract][Full Text] [Related]
31. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
33. Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls.
Forrest IA; Small T; Corris PA
Clin Sci (Lond); 1999 Jul; 97(1):99-102. PubMed ID: 10369800
[TBL] [Abstract][Full Text] [Related]
34. The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism.
Webb SA; Stott S; van Heerden PV
Intensive Care Med; 1996 Apr; 22(4):353-5. PubMed ID: 8708174
[TBL] [Abstract][Full Text] [Related]
35. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
36. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension.
Laflamme M; Perrault LP; Carrier M; Elmi-Sarabi M; Fortier A; Denault AY
J Cardiothorac Vasc Anesth; 2015 Feb; 29(1):38-45. PubMed ID: 25440627
[TBL] [Abstract][Full Text] [Related]
37. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study.
Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
39. The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
Weston MW; Isaac BF; Crain C
J Heart Lung Transplant; 2001 Dec; 20(12):1340-4. PubMed ID: 11744420
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Wax D; Garofano R; Barst RJ
Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
